**Officinal PR :**
[https://www.newswire.ca/news-releases/high-tide-reports-second-quarter-2026-financial-results-featuring-record-revenue-of-179-3mm-and-adjusted-ebitda-of-13-9mm-889092761.html](https://www.newswire.ca/news-releases/high-tide-reports-second-quarter-2026-financial-results-featuring-record-revenue-of-179-3mm-and-adjusted-ebitda-of-13-9mm-889092761.html)
**Q2 FY2026: $179.3M revenue (+30% YoY, fastest growth in 11 quarters), record $13.9M Adjusted EBITDA (+73% YoY), positive net income and free cash flow, plus a $40M BMO credit agreement.**
HITI is becoming the definition of non-stop execution and deserves more credit for this.
Remexian's goal is clear: gain more market share to satisfy this insatiable and ever-growing demand, in order to reach 20-30% market share in the long term and then achieve pricing determination with a consequent increase in GMS and profitability.
Still think $HITI is vastly undiscovered.
In my view, the risk-reward continues to skew firmly in our favor. As I wrote last time in Q1, with every KPI record, my conviction remains at an all-time high
I continue to hold my full position, and I continue to think this is a very attractive risk-reward setup for the next years The market may soon begin to price in the company as a highly efficient retail operator, rather than a "cannabis penny stock."
Strengthening KPIs suggest that current growth is sustainable and less dependent on speculative factors than in the past.
Remexian posted record revenue of $31.6M in Q2, up from $25.0M last quarter, with gross margin more than doubling to 27% as Canadian biomass procured at best-in-class terms flows through the supply chain.
**Feels like markets are only slowly starting to understand the real value of $HITI, next $Cost of #cannabis**.
Record Quarter.
